//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
Profile
Loading...
Researching legal, ethical, and social aspects of Psychedelics at the University of Birmingham. Current project: 'Psychedelics & Regulatory Decision-making'.
PSYCHLES









Loading...
A new excerpt from A World Appears: Minds Before Brains - by Michael Pollan - The Microdose themicrodose.substack.com/p/minds-befo...
@Drug_Science blog on the new Compass #psilocybin for #depression study drugscience.org.uk/compass-phase3
đź“…Save the date! Our next Network seminar will be on "Hearing voices, suicidality, and AI-psychosis", March 20th 2026, Hybrid This is a collaboration with @hearingvoicesmic.bsky.social and #ProjectEPIC Find more info and registration here: birminghamphenomenalnetwork.blogspot.com/2025/12/netw...
Great day with rich discussions. The talks all went so well together. #psychedelics #phenomenology #mentalhealth @uobphenomenal.bsky.social
And we're off to the races. Great lineup for today's @uobphenomenal.bsky.social seminar. Joined by speakers from Imperial, Exeter, Amsterdam, & Birmingham. #psychedelics #interdisciplinary #phenomenology #mentalhealth
Looking forward to the talks at our Psychedelics, Phenomenology, & Mental Health workshop as part of the Birmingham Network for Phenomenology & Mental Health. Sign up & schedule in the link.
🌿 Facing the end of life can bring immense distress. Could psychedelic therapy help ease the journey? drugscience.org.uk/easing-end-of-life-distress-psychedelic-uk @profjoneill.bsky.social, Laura Downey, & @profmq.bsky.social for @drugscience.bsky.social #PalliativeCare #Psychedelics #DrugScience
Pα+ Psychedelic Bulletin #207 - Lykos Rebrands to Resilient - Pharma Pushes Back on Norway’s Ketamine Reimbursement Decision - AbbVie-Gilgamesh Deal Viewed as Validation - Psilocybin Rescheduling Petition Heads to HHS - Much, much more... psychedelicalpha.com/news/p%ce%b1...
The Dutch Medicines Evaluation Board will host a Pipeline Meeting on 5 Nov 2025, focusing on the regulatory development of psychedelics. Pharmaceutical companies can apply to present and discuss psychedelic development challenges with Dutch regulators. Deadline: 29 Aug tinyurl.com/meb-pipeline...
🍄 Our new living systematic review and meta-analysis on psilocybin for depression is out. Here's what we found and the open science infrastructure we built to support it 🧪🧵 www.medrxiv.org/content/10.1...
3mo
3mo
6mo
7mo
7mo
8mo
9mo
9mo
9mo
10mo
An excerpt from my new book
themicrodose.substack.com
Minds Before Brains
From psychedelic trips to treating Treatment-Resistant Depression. The possible gamechanger COMP360
Psychiatric medicine is undergoing a seismic shift as Compass pathways announce successful results from its Phase 3 trial (COMP006).
drugscience.org.uk
Location In person: Assembly Room, The Exchange, 3 Centenary Square, Birmingham, B1 2DR. Online: Teams meeting. Date and time 20th March 202...
birminghamphenomenalnetwork.blogspot.com
Network Seminar: "Hearing voices, suicidality, and AI-psychosis", 20th March, Birmingham and Online
Facing a terminal diagnosis is one of life’s most difficult challenges. Beyond the physical burden of illness, patients often experience anxiety, depression, insomnia, and existential distress – a sen...
drugscience.org.uk
Lykos Therapeutics Rebrands to Resilient Pharmaceuticals • Pharma Pushes Back on Norway’s Off-Label Ketamine Decision • AbbVie–Gilgamesh Deal Viewed as Validation for Short-Acting Psychedelics •
psychedelicalpha.com
Easing End-of-Life Distress: Should Psychedelic Therapy Be Part of Palliative Care in the UK?
Pα+ Psychedelic Bulletin #207: Lykos Rebrands to Resilient; Pharma Pushes Back on Norway’s Ketamine Reimbursement Decision; AbbVie-Gilgamesh Deal Viewed as Validation - Psychedelic Alpha
PSYCHLES
Birmingham Network for Phenomenology and Mental Health
Michael Pollan
PSYCHLES
PSYCHLES
PAREA
josh hardman
PSYCHLES
Parker Singleton
Our schedule for our next network seminar has now been finalised! Check out our website for the full list of awesome talks: birminghamphenomenalnetwork.blogspot.com/2025/10/netw... P.S. there's still time to register!
8mo
Network Seminar: "Psychedelics, Phenomenology, & Mental Health", November 5th 2025, Birmingham and Online
The second seminar in the series organised by the Birmingham Network for Phenomenology and Mental Health will be held on 5 November 2025, 9....
birminghamphenomenalnetwork.blogspot.com
Birmingham Network for Phenomenology and Mental Health
📣Announcing our Psychedelics, Phenomenology, & Mental Health seminar, 5.11.25, Birmingham and Online Drawing on phenomenological perspectives, the workshop will bring together interdisciplinary scholars to discuss the potential of psychedelic experiences for addressing mental health challenges.